Anika Therapeutics (ANIK) Tops Q1 EPS by 12c; $50M Buyback

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. RTX
6. COF
7. SMCI
8. TSLA
9. GOOGL
10. CRWV

Go back to Anika Therapeutics (ANIK) Tops Q1 EPS by 12c; $50M Buyback

Anika Reports First Quarter 2019 Financial Results

May 2, 2019 4:05 PM EDT

Total Revenue Increased 16% Year-over-Year

Solid Bottom Line Performance with $0.31 Diluted EPS

New Leadership Added to Accelerate Innovation and Expand Commercial Reach

Announces $50 Million Share Repurchase Program

BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines... More